Arax Advisory Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5K	Sell	573 -906	-61%	-$23.1K	﹤0.01%	2293
2025 Q4	$43K	Sell	1,479 -5,148	-78%	-$132K	﹤0.01%	1688
2025 Q3	$125K	Buy	6,627 +6,008	+971%	+$94.8K	﹤0.01%	1454
2025 Q2	$8.68K	Buy	619 +567	+1,090%	+$7.95K	﹤0.01%	2027
2025 Q1	$813	Buy	52 +26	+100%	+$366	﹤0.01%	2376
2024 Q4	$363	Sell	26 -718	-97%	-$7.87K	﹤0.01%	2353
2024 Q3	$6.92K	Sell	744 -25	-3%	-$247	﹤0.01%	1565
2024 Q2	$7.15K	Buy	769 +759	+7,590%	+$6.86K	﹤0.01%	1420
2024 Q1	$99	Sell	10 -24	-71%	-$179	﹤0.01%	1290
2023 Q4	$110	Sell	34 -14	-29%	-$38	﹤0.01%	1306
2023 Q3	$255	Hold	48	–	–	﹤0.01%	1272
2023 Q2	$458	Buy	48 +6	+14%	+$67	﹤0.01%	1217
2023 Q1	$462	Buy	42 +8	+24%	+$116	﹤0.01%	1202
2022 Q4	$503	Buy	+34	New	+$594	﹤0.01%	1180